cyclopentane has been researched along with Disease Exacerbation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhya, AK; Jiramongkol, Y; Lam, EW; Mishra, SK; Naik, SK; Parida, DK; Parija, M; Prakash, S | 1 |
| Chen, X; Jin, Y; Wang, Z; Zhao, Y; Zheng, J | 1 |
| Baba, M; Fujimoto, S; Imai, G; Imai, H; Matsuzono, K | 1 |
| Belfiore, A; Brunetti, G; Cirillo, F; Galli, GR; Lappano, R; Maggiolini, M; Miglietta, AM; Rigiracciolo, DC; Santolla, MF; Talia, M; Vivacqua, A | 1 |
| Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M | 1 |
| Chu, Y; Duan, S; Hua, W; Jia, L; Jiang, Y; Li, C; Li, L; Liu, Z; Mao, Y; Yang, M; Yang, Z; Yu, G; Zhang, Y; Zhu, W | 1 |
| Hassan, NM; Hu, GF; Ibaragi, S; Kishimoto, K; Mandai, H; Okui, T; Omori, K; Sasaki, A; Shibata, A; Shimo, T; Suga, S; Takashiba, S; Tsumura, T | 1 |
| Ishii, S; Itoh, Y; Komeda, T; Sanekata, M; Shimada, J; Yoshikawa, T | 1 |
| Chan, CH; Gao, Y; Lin, HK; Wang, G | 1 |
| Lupulescu, A | 1 |
2 review(s) available for cyclopentane and Disease Exacerbation
| Article | Year |
|---|---|
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
Topics: Animals; Cell Movement; Cellular Senescence; Cyclopentanes; Disease Progression; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Pyrimidines; S-Phase Kinase-Associated Proteins; Ubiquitination | 2012 |
Prostaglandins, their inhibitors and cancer.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Cyclopentanes; Disease Progression; Humans; Neoplasm Transplantation; Neoplasms; Prostaglandin Antagonists; Prostaglandins | 1996 |
8 other study(ies) available for cyclopentane and Disease Exacerbation
| Article | Year |
|---|---|
NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression.
Topics: Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cullin Proteins; Cyclopentanes; Disease Progression; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; Humans; NEDD8 Protein; Neoplasm Recurrence, Local; Pyrimidines; Receptors, Estrogen; Ubiquitins | 2020 |
G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
Topics: Bone Neoplasms; Cell Line; Cell Line, Tumor; Cell Movement; Cyclopentanes; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; F-Box Proteins; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Protein Processing, Post-Translational; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Messenger; Snail Family Transcription Factors; Survival Rate; Ubiquitin-Protein Ligase Complexes | 2019 |
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment.
Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Antiparkinson Agents; Antiviral Agents; Cyclopentanes; Disease Progression; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Parkinson Disease; Syndrome | 2019 |
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Topics: Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Movement; Connective Tissue Growth Factor; Culture Media, Conditioned; Cyclopentanes; Disease Progression; Estradiol; Female; Fibroblast Growth Factor 2; Humans; Neoplasm Invasiveness; Paracrine Communication; Proto-Oncogene Proteins c-fos; Quinolines; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Up-Regulation | 2019 |
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays | 2015 |
Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cullin Proteins; Cyclopentanes; Disease Progression; Glioblastoma; Humans; NEDD8 Protein; Pyrimidines; Signal Transduction; Ubiquitins; Xenograft Model Antitumor Assays | 2015 |
Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Disease Progression; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Ribonuclease, Pancreatic | 2016 |
Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
Topics: Acids, Carbocyclic; Administration, Intravenous; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Cyclopentanes; Disease Progression; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Inpatients; Japan; Male; Middle Aged; Neuraminidase; Pregnancy; Risk Factors; Treatment Outcome; Young Adult | 2016 |